Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diphthamide biosynthesis protein 7 is an enzyme essential for the biosynthesis of diphthamide, a unique post-translationally modified histidine residue present on translation elongation factor 2 (eEF2)[1][2][3]. Diphthamide on eEF2 is the target of diphtheria toxin. DPH7 contains a WD40 repeat domain and acts as a methylesterase. It catalyzes the hydrolysis of methylated diphthine (an intermediate generated by Dph5), converting it into diphthine, which is then available for subsequent amidation by Dph6, ultimately yielding diphthamide[1][2][3]. DPH7's enzymatic function is required for complete diphthamide maturation, critical for normal translational fidelity and resistance to diphtheria toxin. Unlike classic methyltransferases, DPH7's methylesterase activity is biochemically unique within the WD40 protein family[1][2]. Mutations or dysregulation of DPH7 have been associated with certain developmental syndromes and cancer, but it is not known to be a direct therapeutic target or drug-binding protein[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diphthamide biosynthesis protein 7 (DPH7).